Purchase Order 75N95D24P00002
Award Date 11/1/23
Potential Completion Date 10/31/24
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Denver, CO 80215, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institutes of Health Clinical Center awarded a purchase order valued at $77,280 to Terumo BCT Inc. (doing business as Caridianbct Inc.) on August 6, 2019. This firm fixed-price contract was issued to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), with an ultimate completion date of August 23, 2021. The contract was performed at the NIH Clinical Center's Bethesda, Maryland location and carried no small...
- Terumo BCT, Inc., doing business as CaridianBCT, has been awarded a firm fixed-price purchase order valued at twenty-five thousand two hundred ninety-eight dollars and twenty-six cents ($25,298.26) by the Department of Health and Human Services' National Institutes of Health Clinical Center. The contract term runs from October 31, 2023 through December 15, 2023. Performance will take place in Lakewood, Colorado. As the prime contractor, Terumo BCT will provide unspecified products or services to...
- Terumo BCT, Inc. was awarded a firm fixed price purchase order in the amount of thirty-six thousand five hundred seventy dollars ($36,570) by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to provide thirty Spectra Optia Apheresis IDL disposables kits. The solicitation requested the specific brand name kits containing six disposables each to support the National Institute on Aging Clinical Research Core's Institutional Review...
- Terumo BCT Inc. was awarded a firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health Clinical Center to provide preventative maintenance services. The $47,177.18 contract has a period of performance through May 9, 2025 at the agency location in Bethesda, Maryland. As a manufacturer of blood and cell technologies, Terumo BCT will support equipment used in apheresis, cell therapy, and transfusion medicine applications at the Clinical Center....
- This federal contract award, valued at $44,963.38, was issued by the National Institutes of Health (NIH) Clinical Center to Terumo BCT Inc., a foreign-owned, for-profit manufacturer of medical devices and blood and cell technology services. The contract is for the procurement of Optia apheresis machines and related preventative maintenance services, with a period of performance from June 27, 2025 to June 26, 2026, and two optional one-year extension periods. This is a firm-fixed-price purchase...
- This is a firm fixed-price purchase order contract awarded by the National Institute on Aging, a civilian federal agency, to Terumo BCT Inc. for a preventative maintenance service agreement for Spectra Optia apheresis systems. The contract has a ceiling value of $14,123.44 and a period of performance ending on October 31, 2025. Terumo BCT Inc. is a foreign-owned, for-profit manufacturer of medical devices that has an established track record of providing specialized medical equipment and...
- The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $46,507 firm fixed-price purchase order to Terumo BCT Inc., a foreign-owned, for-profit manufacturer of medical devices and blood and cell technologies. The contract is for a base year of maintenance and service on a Spectra Optia apheresis system, which is the main cell processing and cell collection platform used in NIAID's biosafety level 3 and 4 research facilities. This...
- This is a purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Terumo BCT Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, valued at $5,472.93, is for a full service maintenance agreement for a Spectra Optia apheresis system. The contract has a completion date of July 8, 2015 and uses a firm fixed price pricing type. Terumo BCT has an established track record of providing specialized medical equipment and services to...
- Terumo BCT Inc., a Colorado-based manufacturer of advanced blood and cell technology medical devices, was awarded a $19,039.92 firm fixed-price purchase order by the National Institute of Allergy and Infectious Diseases (NIAID) on July 9, 2018. The contract represents an option exercise with a performance location in Denver, Colorado, and carries an ultimate completion date of July 8, 2021. This award was not designated as a set-aside contract. Terumo BCT, operating under the doing-business-as...
- The Department of Health and Human Services National Institutes of Health Clinical Center has awarded a $173,189.14 firm-fixed-price purchase order to Terumo BCT Inc., a manufacturer of medical devices and provider of blood and cell technology services. The purpose of the contract is to acquire two Optia Automated Blood Cell Separators to replace the current Spectra Optia systems that have exceeded their recommended service life. This contract was not set aside for any particular business size...